Newsroom
Category
October 9, 2024
The stars aligned perfectly during a night of celebration at the second annual President’s Luminary Honors event at The University of Texas Health Science Center at San Antonio. The annual event, which took place at the soon-to-open UT Health San Antonio Multispecialty and Research Hospital, paid tribute to the legacy of William L. Henrich, […]
October 4, 2024
Simon Gayther, PhD, professor of medicine in the Division of Hematology and Oncology in the Joe R. and Teresa Lozano Long School of Medicine and founding director in the school’s Center for Inherited Oncogenesis at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), received a $500,000 UT System […]
October 3, 2024
Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]
October 2, 2024
Female cancer patients at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, have a new option to preserve their fertility before undergoing treatment. “It is extremely common that cancer patients will experience the loss of fertility and early menopause after gonadotoxic therapies required for many cancer patients,” said […]
October 1, 2024
Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected […]
September 19, 2024
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]